An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors
Clinical trial NCT01397929 · COMPLETED
Trial details
- NCT number
- NCT01397929
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.